Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Best practice for assessing bone health and fracture risk

Written by | 25 Oct 2022

Professor John Carey, Consultant Rheumatologist at Galway University Hospital says the best practice for assessing bone health and fracture risk is to identify people for primary prevention before… read more.

Celebrating Pharmacy Technician Day 18th October 2022

Written by | 18 Oct 2022

In order to celebrate Pharmacy Technician Day 2022 IMI took the opportunity to interview Claire Steele, President of the Association of Pharmacy Technicians UK (APTUK). In this short… read more.

Career pathways for pharmacy technicians

Written by | 18 Oct 2022

Being a pharmacy technician is a fulfilling and rewarding career, and furthermore, pharmacy technicians are always in demand, according to Claire Steele, President of the Association of Pharmacy… read more.

The scope of the pharmacy technician’s role

Written by | 18 Oct 2022

Pharmacy technicians work in a wide variety of settings and have an integral role in ensuring the safe and effective use of medicines. We spoke to Claire Steele,… read more.

Why bladder cancer matters

Written by | 19 Sep 2022

Bladder cancer is the 5th most common tumour in men and the 7-8th most common tumour women, according to Professor Arnulf Stenzl, Head of the Department of Urology in the… read more.

Re-TUR: depends on surgeon skill or tumour biology?

Written by | 19 Sep 2022

Current guidelines recommend a repeat TUR (re-TUR) for T1 bladder tumours but this carries risks and could be avoided if a good, complete TUR is done in the… read more.

Trimodality therapy for MIBC – present and future directions

Written by | 19 Sep 2022

Trimodality bladder preserving treatment (TMT) for muscle invasive bladder cancer is gaining ground but careful patient selection is essential for success – only 10-20 percent of cases fit… read more.

Current trials with intravesical treatment in high-risk BCG-naïve NMIBC

Written by | 19 Sep 2022

Intravesical therapy with chemotherapy or BCG is the recommended adjuvant treatment after TURBT to minimise the risk of recurrence. BCG shortages continue and BCG is not suitable for… read more.

Immunotherapy: Adjuvant immune checkpoint inhibitors for everybody?

Written by | 19 Sep 2022

The introduction of immunotherapy with immune checkpoint inhibitors has improved outcomes in trials. In this video Professor Morgan Roupret explains the current situation regarding immunotherapy and bladder cancer: This session… read more.

Lynch syndrome – what urologists need to know

Written by | 19 Sep 2022

Lynch syndrome, an inherited cancer syndrome, has been prominently associated with colorectal cancer but other organs, including the urinary tract can also be affected. As a hereditary condition,… read more.

The work of Patient Safety Learning

Written by | 17 Sep 2022

Patient Safety Learning (PSL) is a charity that works as an independent voice for system-wide change through policy influencing, campaigning and promoting ‘how to’ resources for patient safety… read more.

Next steps for Patient Safety Learning

Written by | 16 Sep 2022

Helen Hughes, Chief Executive of Patient Safety Learning reflects on what has been learned over the past two years in the field of patient safety and outlines some… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.